Literature DB >> 1496896

Venomous snakebite: past, present, and future treatment options.

J R Blackman1, S Dillon.   

Abstract

BACKGROUND: Venomous snakebites continue to cause great morbidity, and treatment options are confusing the attending physician. In the United States approximately 45,000 snakebites occur each year, of which some 8000 are by 20 species of venomous snakes.
METHODS: Information on venomous snakes and snakebite treatment was gathered from the libraries of the Wilderness Medical Society and the Rocky Mountain Center for Wilderness Medicine in Boise, Idaho (co-supported by the Boise State University and the Family Practice Residency of Idaho), as well as from current literature files of physicians practicing wilderness medicine. RESULTS AND
CONCLUSIONS: Three genera of venomous snakes account for the majority of poisonous snake envenomations in this country. Most hospitalized victims are bitten either by rattlesnakes or copperheads or by unidentified snakes. Most of these bites occur during the summer months and are found on the extremities. Field treatment focuses on the application of a vacuum extractor and transportation to the nearest medical facility. Although constriction band use can be helpful, tourniquets, incision and suction, and ice therapy are contraindicated. Electric shock therapy is of no use and could cause serious injury. Hospital management focuses on rapid clinical evaluation and laboratory tests to establish the degree of envenomation, looking for clotting abnormalities. If envenomation has occurred and is reactive, polyvalent antivenin should be administered according to the degree of envenomation. Errors in diagnosis and treatment result in increased morbidity and put attending physicians at risk for litigation. Prevention remains the most successful approach to snakebite management.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1496896

Source DB:  PubMed          Journal:  J Am Board Fam Pract        ISSN: 0893-8652


  6 in total

1.  Rattlesnake bite in a patient with horse allergy and von Willebrand's disease: case report.

Authors:  I Dubinsky
Journal:  Can Fam Physician       Date:  1996-11       Impact factor: 3.275

Review 2.  Clinical applications of commonly used contemporary antidotes. A US perspective.

Authors:  C A Bowden; E P Krenzelok
Journal:  Drug Saf       Date:  1997-01       Impact factor: 5.606

3.  Incidence of snake bites in kashan, iran during an eight year period (2004-2011).

Authors:  Rouhullah Dehghani; Davarkhah Rabani; Morteza Panjeh Shahi; Mehrdad Jazayeri; Mohammd Sabahi Bidgoli
Journal:  Arch Trauma Res       Date:  2012-08-21

4.  Preparation and Evaluation of a Horse Antiserum against the Venom of Sea Snake Hydrophis curtus from Hainan, China.

Authors:  Bo Wang; Guoyan Liu; Min Luo; Xin Zhang; Qianqian Wang; Shuaijun Zou; Fuhai Zhang; Xia Jin; Liming Zhang
Journal:  Toxins (Basel)       Date:  2022-04-01       Impact factor: 5.075

5.  The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths.

Authors:  Anuradhani Kasturiratne; A Rajitha Wickremasinghe; Nilanthi de Silva; N Kithsiri Gunawardena; Arunasalam Pathmeswaran; Ranjan Premaratna; Lorenzo Savioli; David G Lalloo; H Janaka de Silva
Journal:  PLoS Med       Date:  2008-11-04       Impact factor: 11.069

6.  The new algorithm for calculation of median lethal dose (LD50) and effective dose fifty (ED50) of Micrarus fulvius venom and anti-venom in mice.

Authors:  Saganuwan Alhaji Saganuwan
Journal:  Int J Vet Sci Med       Date:  2016-11-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.